Trazodone Hydrochloride
Product Images NDC 42549-546
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Trazodone Hydrochloride (NDC 42549-546). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Stat Rx Usa Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Structure (Trazadone 1)
Table1 (Trazadone 2)
The text presents a table with information related to the difference in the number of cases of suicidality per 1000 patients treated with drug or placebo, by age range. For patients younger than 18, the drug was associated with 14 additional cases compared to placebo. In the 18-24 age range, there were 5 additional cases. For patients between 25-64 years old, there were 1 fewer case than placebo. The table includes a total of 265 cases, with 6 fewer cases related to the drug compared to placebo.*
Table2 (Trazadone 3)
This appears to be a table of symptoms reported by patients and their corresponding frequency in percentage. The symptoms are classified into different categories such as nervous, cardiovascular, gastrointestinal, neurological, etc. The table lists out symptoms such as blurred vision, constipation, dry mouth, hypertension, shortness of breath, dizziness, headache, fatigue, insomnia, abdominal disorders, among others. The table seems to be a result of a survey or study but without proper context not much can be inferred from it.*
50mg-score (Trazadone 4)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.